
Oglim G 2mg/500mg Tablet SR
Marketer
Nexkem Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Oglim G 2mg/500mg Tablet SR
DiaBeta Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. DiaBeta Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) may be recommended by your doctor.
Primary Ingredients of Oglim G 2mg/500mg Tablet SR
There is no text provided to rephrase.
Uses of Oglim G 2mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Oglim G 2mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or break it. Consume the Oglim G 2mg/500mg Sustained-Release tablet with food.
Common Side effects of Oglim G 2mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Oglim G 2mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Oglim G 2mg/500mg sustained-release tablet should be administered with a meal.
How Oglim G 2mg/500mg Tablet SR works:
Oglim G 2mg/500mg Extended-Release Tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Oglim G 2mg/500mg SR tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Oglim G 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Prolonged-release Oglim G 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Oglim G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Oglim G 2mg/500mg SR tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Oglim G 2mg/500mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is usually prescribed; however, it's contraindicated in severe cases.
What if you forget to take Oglim G 2mg/500mg Tablet SR :
Should you forget to take your Oglim G 2mg/500mg SR tablet, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oglim G 2mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
